Pricing Log in Create free account
Saturday 7 November 2026 Export CYH’s income statement to Excel — free account

Community Health Systems, Inc.

CYH Healthcare Medical Care Facilities

Community Health Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $12.5 billion, down 1.18% from fiscal 2024.

Revenue
−10.7%
EPS
−138.0%
Free cash flow
+857.1%
Total debt
−9.61%

Quarter to September 2026, against a year earlier

2.21 0.07 −3.07%
Market cap
$321.5M
P/E
4.2×
Fwd P/E
−5.0×
Dividend yield
—
F-score
8/9
Altman Z
1.05
Beneish M
−2.52
Dividend safety
35/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Insider Decisions last twelve months

Sold, $m 0.12
Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — 1 — — —
Insider Ownership 18.93%

Capital & Financial Ratios $m

Size
Market Cap 321.54
Revenue ttm 11,653.00
Net income ttm 188.00
Free cash flow ttm (122.00)
Net debt Q 9,431.00
Valuation
P/E 4.16
Forward P/E (5.00) (negative: loss-making)
Price / sales 0.03
Forward P/S Powerpack
Price / FCF 0.00
Price / book 0.00
Financial health
Current ratio Q 1.48
Debt / equity Q (7.53) (negative: negative equity)
Interest coverage Q 0.73
Growth
Revenue growth Q −10.69% (below 0%: shrinking)
Operating income growth Q −39.92% (below 0%: shrinking)
EPS, this year −208.93% (below 0%: weak)
EPS, next year A +27.92% (at or above 15%: strong)
Revenue, next year A −8.67% (below 0%: weak)
EPS, past 5 yrs −3.00% (below 0%: weak)
EPS, next 5 yrs A +49.85% (at or above 15%: strong)

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 0.8×, against a ten-year median of 1.0×; over the ten years it ranged from 0.8× in 2026 to 1.1× in 2021.
P/E against its own 10 years 62.87%
10-year low 10-year high
P/S against its own 10 years 7.88%
10-year low 10-year high
EV/Sales against its own 10 years 6.74%
10-year low 10-year high

Dividends

Yield
—
Annual rate
—
Payout ratio
—

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 38 37 260 155
Receivables 2,231 2,286 2,077 2,102
Inventory 328 331 322 268
Other 275 358 381 289
3,208 3,301 3,234 2,999
2023 2024 2025 Q'26
Payables 912 913 842 831
ST’ Debt 21 20 16 18
Other — — — —
2,142 2,345 2,208 2,021

Compound Annual Growth %

10y 5y 3y
Sales (4.33%) 1.15% 0.74%
Cash Flow (5.15%) (24.26%) 21.87%
Earnings 12.41% (0.08%) 122.84%
Book Value 0.00% 0.00% 0.00%

Earnings Trends EPS, adjusted, against the consensus

Q3 FY26 Estimate −0.22 Actual −0.48

Earnings per share against the consensus, by quarter
Quarter Estimate Reported Result
Q4 FY25 −0.32 0.00 Beat by 0.32
Q1 FY26 −0.18 −0.48 Miss by 0.30
Q2 FY26 −0.18 −0.19 Miss by 0.01
Q3 FY26 −0.22 −0.48 Miss by 0.26
Q4 FY26 0.03 — Reports 17 February 2027

EPS $

Mar Jun Sep Dec Year
’26 (0.43) 0.51 (0.37) — —
’25 (0.10) 2.09 0.96 0.81 3.77
’24 (0.32) (0.10) (2.95) (0.53) (3.90)
’23 (0.40) (0.29) (0.69) 0.35 (1.02)
’22 (0.01) (2.52) (0.32) 3.18 0.35
’21 (0.51) 0.04 0.85 1.34 1.76
’20 0.15 0.61 0.97 2.57 4.39
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 2,965 2,825 2,757 — —
’25 3,159 3,133 3,087 3,106 12,485
’24 3,140 3,140 3,090 3,264 12,634
’23 3,108 3,115 3,086 3,181 12,490
’22 3,111 2,934 3,025 3,141 12,211
’21 3,013 3,007 3,115 3,233 12,368
’20 3,025 2,519 3,126 3,119 11,789
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (297) 88 154 — —
’25 120 88 69 266 543
’24 96 101 67 216 480
’23 5 86 29 90 210
’22 101 53 137 9 300
’21 101 179 120 (531) (131)
’20 57 1,653 392 76 2,178
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (373) 12 67 — —
’25 35 2 7 172 216
’24 4 16 (2) 107 125
’23 (112) 0 (98) (19) (229)
’22 4 (34) 67 (114) (77)
’21 (2) 73 2 (663) (590)
’20 (42) 1,562 269 (47) 1,742
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

3.2
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Sep ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue 18,438 15,353 14,155 13,210 11,789 12,368 12,211 12,490 12,634 12,485 11,653 (4.2%) 11,403 11,463 11,847 (1.7%)
Gross margin, % 83.67 82.60 83.36 83.72 83.35 83.49 83.83 84.04 84.60 85.07 85.45 +1.4 pt
EBT (1,715) (2,833) (715) (430) 422 499 349 207 (283) 724 412 n/m
EBT margin, % (9.30) (18.45) (5.05) (3.26) 3.58 4.03 2.86 1.66 (2.24) 5.80 3.54 +15.1 pt
Net income (1,626) (2,396) (704) (590) 607 368 179 16 (362) 676 188 n/m
Per share, $
Per share, $ Revenue 166.51 137.36 125.57 116.14 102.08 97.57 94.80 95.75 95.64 93.48 85.97 (6.2%)
Earnings (15.54) (22.00) (6.99) (5.93) 4.43 1.82 0.35 (1.02) (3.90) 3.81 0.53 n/m
Cash flow 10.27 6.92 2.43 3.38 18.86 (1.03) 2.33 1.61 3.63 4.07 1.56 (9.8%)
Capex (6.58) (4.98) (4.60) (3.82) (3.78) (3.62) (2.93) (3.37) (2.69) (2.45) (2.46) (10.4%)
Free cash flow 3.68 1.93 (2.17) (0.44) 15.08 (4.65) (0.60) (1.76) 0.95 1.62 (0.90) (8.7%)
Book value 15.61 (6.19) (12.98) (18.82) (13.32) (10.18) (9.90) (8.79) (12.69) (8.68) (9.39) n/m
Shares, m 111 112 113 114 115 127 129 130 132 134 135 +2.1%
Valuation, ×
Valuation, × P/E 0.00 0.00 0.00 0.00 1.70 7.39 12.22 0.00 0.00 0.82 4.16 2.2
P/S 0.03 0.03 0.02 0.03 0.07 0.14 0.05 0.03 0.03 0.03 0.03 0.0
P/B 0.37 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.0
EV/Sales 0.85 0.90 0.97 1.02 0.97 1.08 0.99 0.95 0.93 0.85 0.84 1.0
EV/FCF 38.36 64.12 (55.99) (270.38) 6.54 (22.58) (156.93) (51.80) 94.48 48.86 (79.76) (30.5)
Cash, $m
Cash, $m Operating cash flow 1,137 773 274 385 2,178 (131) 300 210 480 543 211 (7.9%)
Capex (729) (557) (519) (435) (436) (459) (377) (439) (355) (327) (333) (8.5%)
Free cash flow 408 216 (245) (50) 1,742 (590) (77) (229) 125 216 (122) (6.8%)
Balance, $m
Balance, $m Working capital 1,779 1,712 1,157 1,145 1,695 1,115 896 1,066 956 1,026 978 (5.9%)
Net debt 15,006 13,350 13,400 13,189 10,540 11,633 11,517 11,449 11,415 10,136 9,431 (4.3%)
Shareholders’ equity 1,728 (692) (1,463) (2,141) (1,538) (1,290) (1,275) (1,147) (1,676) (1,159) (1,273) n/m
Returns, %
Returns, % ROA (7.09) (12.48) (4.73) (4.29) 3.23 1.47 0.31 (0.91) (3.62) 3.73 0.28 +10.8 pt
ROIC (3.21) (9.27) 1.09 3.68 7.82 8.47 5.01 5.81 3.48 10.36 9.69 +13.6 pt
ROE (59.01) (474.71) 73.13 37.46 (27.78) (16.27) (3.59) 10.98 36.56 (35.91) (2.83) +23.1 pt
People
People Employees 120,000 113,000 87,000 80,000 70,000 66,000 66,000 61,000 60,000 57,000 — (7.9%)
Revenue/emp, $m 0.15 0.14 0.16 0.17 0.17 0.19 0.19 0.20 0.21 0.22 — +4.0%
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Sep 2026 · fundamentals updated 6 Nov 2026

Community Health Systems, Inc. vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
GMRS GMR Solutions Inc. $675.8M 15.8× — — n/m — 100.00% 3.80% Compare
STLN Starling Oncology, Inc. $669.9M — (loss-making) — (loss-making) +24.31% (above 0%: growing) n/m +167.10% (above 0%: growing) 0.00% (1.76%) Compare
MCTA Charming Medical Limited $497.3M — — — — — — — Compare
SRTA Strata Critical Medical, Inc. $469.8M — (loss-making) — (loss-making) +50.27% (above 0%: growing) n/m +121.34% (above 0%: growing) 22.70% (5.17%) Compare
AUNA Auna S.A. $339.7M 66.7× 6.1× +20.51% (above 0%: growing) −61.29% (below 0%: shrinking) +121.08% (above 0%: growing) 35.72% 13.09% Compare
CYH Community Health Systems, Inc. $321.5M 4.2× — (loss-making) −10.69% (below 0%: shrinking) n/m +857.14% (above 0%: growing) 85.24% 5.30%
JYNT The Joint Corp. $104.2M 25.5× 20.1× +14.41% (above 0%: growing) +400.00% (above 0%: growing) +432.31% (above 0%: growing) 83.68% (2.43%) Compare
AIRS AirSculpt Technologies, Inc. $103.8M — (loss-making) — (loss-making) −8.71% (below 0%: shrinking) n/m −813.83% (below 0%: shrinking) 0.00% 0.00% Compare
PARK Park Dental Partners, Inc. $95.8M — (loss-making) — +12.15% (above 0%: growing) −65.84% (below 0%: shrinking) −34.78% (below 0%: shrinking) 14.37% 1.90% Compare
Median of peers $404.8M 25.5× — +17.46% −61.29% +121.21% 22.70% 0.00%

All 51 Medical Care Facilities stocks →

Pay and ownership Proxy statement filed 2 April 2026

Ownership

Directors and executive officers, together 11.10%
Apollo Management Holdings GP, LLC 8.40%
Blackrock, Inc. 6.90%
CastleKnight Master Fund, LP 6.90%
The Vanguard Group 6.00%
Eversept Partners, L.P. 5.60%
Wayne T. Smith 5.40%
Nomura Holdings, Inc. 5.20%
Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

Community Health Systems, Inc. (CYH) Latest News

2 Nov

Impact 4 · · healthcaredive.com

30 Oct

Impact 4 · · Simply Wall St.
Impact 3 · · MarketBeat transcript

29 Oct

Impact 4 · · The Motley Fool transcript
Impact 4 · · Moby transcript

28 Oct

Impact 4 · · Business Wire
Impact 3 · · Zacks
Impact 3 · · Zacks
Impact 3 · · Associated Press

25 Sep

Impact 3 · · Zacks

24 Jul

Impact 3 · · healthcaredive.com

23 Jul

Impact 3 ·
Impact 3 · · MarketBeat transcript
Impact 3 ·
Impact 3 · · Moby

22 Jul

Impact 4 ·
Impact 3 ·
Impact 3 ·

16 Jul

Impact 3 ·

23 Jun

Impact 3 · · Zacks
Impact 3 · · Simply Wall St.

7 Jun

Impact 4 · · Simply Wall St.

2 Jun

Impact 3 · · Zacks

1 Jun

Impact 3 · · joplinglobe.com

6 May

Impact 4 · · Business Wire

23 Apr

Impact 4 · · MarketBeat
Impact 4 · · GuruFocus.com
Impact 3 · · healthcaredive.com

22 Apr

Impact 4 · · Business Wire
Impact 4 · · Zacks
stockrow.com/CYH · Data as of Nov 6, 2026 · For information only; not investment advice. · © 2026 stockrow.com